Literature DB >> 2556279

Absorption of oral enalapril in germ-free and microbially-associated rats.

K Pelkonen1, P Ylitalo.   

Abstract

The effect of microbial status and presence of food in the gastrointestinal (GI) tract on absorption of an orally administered antihypertensive drug [14C]-enalapril (1 mg/10 microCi/kg body weight) was studied in non-fasted and fasted germ-free (GF) and microbially-associated (MA) rats. The absorption was evaluated from blood samples taken 0.5, 2 and 4 h after the administration of enalapril. Drug levels in the lungs, liver, and duodenal mucosa were also measured by counting [14C]-radioactivities at 4 h after the drug administration. During the 4 h monitoring period enalapril was poorly absorbed in non-fasted rats as compared to fasted animals. In non-fasted rats, the absorption of enalapril was slightly slower in GF than in MA rats. In fasted rats, no difference was found between GF and MA animals. The results show that food in the GI tract substantially lowers or retards the absorption of enalapril in rats. The GF status of the GI tract, however, did not substantially affect the absorption of the ester-type drug enalapril.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556279     DOI: 10.1007/BF03190848

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  12 in total

1.  Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

Authors:  J Lieberman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Influence of food on the bioavailability of drugs.

Authors:  A Melander
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

4.  Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.

Authors:  M L Cohen; K D Kurz
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

5.  Effect of food on the bioavailability of captopril in healthy subjects.

Authors:  S M Singhvi; D N McKinstry; J M Shaw; D A Willard; B H Migdalof
Journal:  J Clin Pharmacol       Date:  1982 Feb-Mar       Impact factor: 3.126

6.  On the inducibility of cytosolic and microsomal carboxylesterase by phenobarbital in rat tissues.

Authors:  U Nousiainen; O Hänninen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-07

7.  The physiological disposition and metabolism of enalapril maleate in laboratory animals.

Authors:  D J Tocco; F A deLuna; A E Duncan; T C Vassil; E H Ulm
Journal:  Drug Metab Dispos       Date:  1982 Jan-Feb       Impact factor: 3.922

Review 8.  Role of gut in xenobiotic metabolism.

Authors:  O Hänninen; P Lindström-Seppä; K Pelkonen
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

9.  The clinical pharmacology of enalapril.

Authors:  H J Gomez; V J Cirillo; K H Jones
Journal:  J Hypertens Suppl       Date:  1983-10

10.  Absorption of Ca45 and Sr85 from solid and liquid food at various levels of the alimentary tract of the rat.

Authors:  C S Marcus; F W Lengemann
Journal:  J Nutr       Date:  1962-06       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.